📋 Tender Overview
Microbiome-Derived Asthma And Allergy Protective Substances For Prevention
Strategies To Stop The Asthma And Allergy Epidemicasthma Affects Both Children And Adults. However, It Is The Most Common Chronic Disease Among Children. It Is Estimated That One In 10 School-Age Children Suffer From Asthma. Allergies Are Also Very Prevalent, With Up To 50 % Of Children Being Diagnosed With Them. Unfortunately, There Is No Cure Or Effective Prevention Available. The Erc-Funded Aprosus Project Will Advance The Field Of Microbiome Research Towards In-Depth Characterisation Of Microbe-Derived Metabolite Complexes To Better Understand Their Associated Asthma And Allergy Protective Properties. Project Work Will Be Based On Previous Studies Carried Out By The Team, Whereby Both Asthma And Allergies Were Explored Together, Identifying Relevant Taxa Of The Environmental Microbiome And Discovering Microbiome-Derived Functional Agents Conferring Protection.
Funded Under
European Research Council (Erc)
Total Cost
€ 2 500 000,00
Eu Contribution
€ 2 500 000,00
Coordinated By
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt Gmbh
Germany
